Marc Tessier-Lavigne, Director at AGIOS PHARMACEUTICALS INC (AGIO), bought 55,555 shares at $18.00 ($1000K) on 2013-07-24, disclosed to the SEC on 2014-04-03.
Open-market purchase of $1000k AGIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |